×
AIFU Inc. (AIFU) is trading down -5.56% during regular market hours, last at $10.70 versus the prior session close of $11.33. The decline follows ongoing dilution concerns tied to a $135 million private placement priced at a deep discount in mid-October.
ZBAO shares have tumbled roughly 92% over the past 30 days, falling from about $4.85 to approximately $0.40. The slide extends a longer decline, with the stock down roughly 97% over the trailing quarter.
ZBAO shares fell -9.09% during regular trading, sliding from a $0.44 prior close toward $0.40 intraday. The decline extends a multi-session pullback following the company's Oct. 8 1-for-50 reverse stock split as investors reassess post-split valuation.
TWFG is trading down -7.53% to $26.51 during the regular session, reversing yesterday's +8.64% surge to $28.67. The decline reflects profit-taking after the prior session's sharp, high-volume spike, with no new company-specific news driving the reversal.
NP has traded in a narrow range over the past 30 days, down roughly 1.5%, consolidating near $28 after an earlier pullback from August highs above $34. Neptune delivered record third-quarter 2026 results: revenue of $59.6 million (up 34% year over year) and adjusted EBITDA of $36.8 million (up 38%) at a 62% margin.
NP shares fell -4.37% to $28.20 during regular trading, down from a prior close of $29.49. The drop came despite record Q3 results: revenue +34% YoY to $59.6M, adjusted EBITDA +38%, and raised FY2026 guidance to $204M.
Third-quarter revenue rose 34% year over year to a record $59.6 million. Adjusted diluted earnings per share (EPS) came in at $0.17, modestly ahead of the $0.16 consensus estimate.
Neptune Insurance Holdings (NYSE: NP) is scheduled to report third-quarter 2026 results, for the period ended September 30, 2026, after the market close on October 20, 2026. The Zacks Consensus Estimate calls for earnings of $0.16 per share on revenue of $54.97 million .
MRSH shares rose roughly 6% over the trailing 30-day period, recovering from a September pullback after a strong third-quarter earnings report released on October 15, 2026. Third-quarter revenue increased 8% to $6.9 billion, while adjusted earnings per share grew 10% year over year to $2.03.
Marsh & McLennan reported third-quarter 2026 revenue of $6.86 billion, beating the consensus estimate of $6.64 billion. Adjusted earnings per share (EPS) came in at $2.03, above analyst expectations of $1.97 and up 10% from $1.85 a year earlier.
YRD is a China-based financial technology (fintech) firm whose shares have been whipsawed in recent weeks by a leadership and regulatory crisis, falling roughly 89% over the past 12 months. ZBAO is a Chinese insurance technology (insurtech) broker that recently completed a 1-for-50 reverse stock split while raising capital through a Bitcoin-backed private placement.
NIVF (NewGenIvf Group) is a micro-cap fertility and technology-focused healthcare company, while ZBAO (Zhibao Technology) provides digital insurance brokerage and underwriting services in China. Both stocks have experienced sharp price declines and elevated volatility over the trailing 12 months, making this comparison most relevant to risk-tolerant, momentum-oriented traders.
AMTD is a diversified investment-holding and financial-services conglomerate, while ZBAO is a Shanghai-based digital insurance brokerage, or InsurTech, company. Both stocks trade at sub-dollar levels and have faced exchange listing-compliance pressure in recent months.
Treasure Global ( TGL ) is a Southeast Asia–anchored technology company, while Zhibao Technology ( ZBAO ) is a China-based digital insurance (insurtech) platform — two very different business models and risk profiles. Both are small-cap, pre-profitability companies that have experienced sharp share-price declines and elevated volatility over the past year.
GLND (Greenland Energy Company) is an early-stage, pre-revenue oil and gas explorer targeting East Greenland's Jameson Land Basin, while ZBAO (Zhibao Technology Inc.) operates an established digital insurance business in China. GLND has exhibited extreme price volatility, with sharp spikes driven largely by headlines about Arctic resource development rather than confirmed operational milestones.
MGOL (MGO Global) is a micro-cap, digitally native consumer-brand platform, while ZBAO (Zhibao Technology) is a Chinese insurtech (insurance technology) firm providing digital insurance brokerage and underwriting services. The two names operate in unrelated industries, making this a study in contrasting risk profiles, volatility, and market positioning rather than a same-sector rivalry.
VSTM is a commercial-stage oncology biotech with a validated drug and a rising revenue base, while ZBAO is a micro-cap Chinese digital insurance broker navigating Nasdaq compliance risk. Verastem recently reported encouraging early-stage data for its KRAS-targeting drug candidate and raised roughly $250 million, lifting shares sharply in recent weeks.
Both NXGL and ZBAO are small-capitalization, loss-making companies that have experienced sharp share-price declines over the trailing year. NXGL is a U.S. hydrogel and consumer-beauty manufacturer pivoting toward medical devices and regenerative medicine.
FMFC (Kandal M Venture Limited) is a Cambodia-based contract manufacturer of affordable luxury leather goods, while ZBAO (Zhibao Technology Inc.) is a China-based InsurTech and digital insurance brokerage. Both are volatile micro-cap Nasdaq listings that have experienced sharp drawdowns and, in ZBAO's case, a recent reverse stock split.
Two very different business models: BDRX is a pre-revenue, clinical-stage biopharmaceutical company, while ZBAO is a revenue-generating Chinese InsurTech (insurance technology) broker. Both are micro-cap, high-volatility names that have recently undergone or proposed major share-capital restructuring, amplifying risk for shareholders.